Skip to main content
Fewer than 10% of eligible type 2 diabetes patients get new, pricey drugs
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Fewer than 10% of eligible type 2 diabetes patients get new, pricey drugs
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
SGLT2 Inhibitor
0
0.95
GLP-1 Receptor Agonist
0
0.43
Receptors
0
0.32
Renal Disease
0
0.22
Chronic Kidney Disease
0
0.21
Renal Failure
0
0.21
Type 1 Diabetes Mellitus
0
0.17
Cardiovascular disease
0
0.16
Chronic Disease
0
0.16
Clinical Guidelines
0
0.16
Clinical Research
0
0.16
Europe
0
0.16
Kidney
0
0.16
Nutrition
0
0.16
Stress
0
0.16
Cardiovascular Risk Management
0
0.12
Healthcare and Medical Technology
0
0.12
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Nephrology
0
0.34
Gastroenterology
0
0.17
Cardiology
0
0.12
Edit Tags